In the evolving landscape of molecular research, the development of specialized compounds remains a focal point for those interested in high-precision labeling techniques. My personal exploration into the world of radiochemistry has led me to study the gallium Ga 68-labeled DOTA Di-HSG peptide IMP-288, a sophisticated molecule that continues to pique the interest of researchers globally.
Understanding the Molecular Architecture
At its core, IMP288 is a DOTA-conjugated tetrapeptide that serves as a critical component in advanced binding studies. The structural complexity of this molecule is what makes it so fascinating. It features two HSG (histamine-succin gallium Ga 68-labeled DOTA Di-HSG peptide IMP-288. A radiolabeled divalent histamine-succinyl-glycine (HSG) hapten-peptide linked with the macrocyclic chelator Read more yl-glycine) hapten structures, which are essential for its function as a DOTA-conjugated, HSG-containing peptide IMP 288.
The inclusion of the DOTA macrocyclic chelator is vital, as it allows for the stable complexation of 68Ga. When we look at the DOTAcontaining IMP288 peptide, we see a clear ex by F Musumeci·2025·Cited by 5—In particular,68Ga-DOTA-TOC received the orphan designation from the FDA in 2014 [62] and was successively approved in 2019 [63],68Ga-DOTA- Read more ample of how modern design facilitates specific chemical interactions. This labeled peptide is meticulously engineered to ensure that the 68Ga-IMP-288 complex maintains high stability during experimental procedures.
The Role of Gallium-68 in Advanced Labeling
The use of 68Ge and 68Ga generators has revolutionized the efficiency of Ga labeling. In my review of the literature, it is evident that labeling a targeting agent with Ga-68 requires precise control over temperature and pH to achieve optimal radiochemical yields. The IMP-288 peptide labeled with gallium-68 represents a significant advancement in targeted imaging and therapy, as it offers a rapid clearance profile from Injection of a bispecific anti-CEA x anti-HSG antibody TF2 (120 nmoles) and 30 hours laterIMP-288 peptide labeled with gallium-68(3 to 6 nmoles/150 MBq). A Read more the blood, which is a highly desirable trait in any new gallium-68 radiolabeled peptide.
Comparing Technical Specifications
To understand why this specific peptide is so widely discussed in scientific circles, we must look at its components:
* Chelator: DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid).
* Hapten: Di-HSG (histamine-succinyl-glycine).
* Isotope: 68Ga (derived from a 68Ge/68Ga generator).
* Peptide Classification: A di-HSG functionalized tetrapeptide.
The IMP288 construct is frequently compared to other radiogallium agents, such as Gallium Ga 68-HA-DOTATATE or DOTATOC. While those agents are well-established for their affinity to specific receptors, the IMP288 system is unique because it is designed for pretargeting strategies, METHODS OF IMAGING WITH Ga-68 LABELED utilizing a bispecific antibody to capture the labeled di-HSG hapten.
Why This Matters for Research
The precision afforded by 68 labeled DOTA bioconjugates is remarkable. In practice, the effectiveness of an agent like 68Ga relies heavily on the purity and specific activity of the final product. Researchers often investigate the pharmacokinetics of IMP288 to ensure that the 288 variant performs consistently across different experimental models.
The 68 Ga isotope, with its relatively short half-life, necessitates a streamlined labelling process. My analysis of these labelled peptides suggests that the synergy betw 68Ga-IMP-288: a Histamine succinyl glycine modulators Drug, Initially developed by Gilead Sciences, Inc., Now, its global highest R&D status is Pending, een the IMP backbone and the HSG moieties is what allows for such high specificity. Whether one is working with 68Ga-IMP-288 or other peptides in the series, the underlying chemistry remains a masterclass in modular design.
Final Thoughts on Experimental Utility
The journey of IMP-288 from development to its current status as a benchmark in HSG peptide research highlights the importance of rigorous chemical validation. As we continue to refine the synthesis of these mole by A Chopra·2011·Cited by 1—Size-exclusion chromatography analysis of a [111In]-IMP-288/TF10 mixture showed that 90% of thelabeled peptidewas bound to the trivalent bsmAb Read more cules, the focus remains on enhancing the binding affinity and stability of the Ga complex. For those of us fascinated by the intersection of synthetic chemistr by A Moussaron·2021·Cited by 13—Here, we describe the synthesis and the photophysical properties of thenew gallium-68 radiolabeled peptideto target NRP-1.Read more y and molecular tracking, the gallium Ga 68-labeled DOTA Di-HSG peptide IMP-288 remains a definitive example of how structural customization can drive progress in the field.